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Heart failure (HF) is a significant public health concern. HF clinics provide 
the optimal environment to address the needs of these patients and improve 
outcomes. The growing population of HF patients outstrip the ability of these 
clinics to deliver care. The spoke-hub-and-node model represents an 
organization of care working collaboratively with the primary care sector and is 
highly integrated with community-based multidisciplinary teams of health care 



















































Heart failure (HF) is a significant public health concern. Specialized HF clinics 
provide the optimal environment to address the complex needs of these patients 
and improve outcomes. The current and growing population of HF patients  
outstrip the ability of these clinics to deliver care. Integrated care is defined as  
health services that are managed and delivered so that people receive a  
seamless continuum of health promotion, disease prevention, diagnosis,  
treatment, disease-management, rehabilitation and palliative care services. This  
approach requires coordination across different levels and sites of care within  
and beyond the health sector, according to changing patient needs throughout  
their life. The spoke-hub-and-node (SHN) model represents an organization of  
care that works collaboratively with the primary care sector and is highly  
integrated with community-based multidisciplinary teams of health care  
professionals and specialty care. The purpose of the present paper is to analyze  
the requirements for successful implementation of SHN models. We consider the  
respective roles of HF Clinics, HF nurse specialists, pharmacists, palliative care  
teams, telemonitoring, and solo practitioners. We also discuss levels of care  
delivery and the importance of patient stratification and patient flow. The SHN  
approach has the potential to build on and improve the chronic care model  
(CCM) to deliver centralized services to preserve quality, patient-centered care at  
































































































Heart failure (HF) is a significant public health concern affecting more than 
500,000 Canadians. HF cases have increased 13% from 2010 to 2016, with a 
continued expected rise, greatly due to the aging population1,2 HF prevalence is 
approximately 3.5%, increasing with age to about 23% for those over age 85.1 
Annual mortality is approximately 12% overall, approaching 25% among those 
over age 85.1 There are over 75,000 new cases each year and over 60,000 
patients die each year1. Despite present management 50% of patients die within 
five years of diagnosis.3–5 
HF represents the second leading cause of hospital admissions for 
Canadians over the age of 65, and the fifth cause of medical admissions.6 
Compared to admissions for other medical conditions, HF patients have more 
comorbidities (3.9 versus 2.3), in hospital mortality (13.3% versus 4.4%) and 
longer length of stay (12 days versus 6.4 days).7 Following discharge these 
patients experience a 30-day mortality rate of 16% and 1-year mortality rate of 
25%.8 
Approximately 25-50% of patients return to hospital within 30-days of 
discharge.9 HF re-hospitalizations strongly predict poor outcomes.10 As a result 
the costs are more than 2.8 billion dollars annually, or around 1% of Canada’s 
GDP.9,11,12 System planning for HF management must consider patient 
complexity and increasing prevalence.  This review examines the concept of 
chronic disease management (CDM), the effect of HF management programs 
and a systems approach to HF. 
 
INTEGRATED CARE IN HF 
HF is a complex chronic condition requiring system integration. Integrated care is 
defined as health services that are managed and delivered so that people 
receive a seamless continuum of health promotion, disease prevention, 
diagnosis, treatment, disease-management, rehabilitation and palliative care 
services. These are coordinated across different levels and sites of care within 
and beyond the health sector and according to their needs throughout the life 
course.13,14 Integrated care is demonstrated by two principle characteristics. First 
is the requirement to bring together key aspects in the design and delivery of 
fragmented systems. Second, there must be care delivered to those in need. The 
Chronic Care Model (CCM) is consistent with the integrated care concept.15 The 
Canadian Heart Health Strategy Action Committee recommended the CCM for 
cardiovascular disease.16 The CCM elements include healthcare organization, 
community resources, self-management support, delivery system design, 
decision support and clinical information systems.17,18 The CCM strength is 
patient-centered care incorporating timely access and a strategy for self-care 
management, leading to improved outcomes including improved quality of life 
(QOL).19–21 There are various independent, integrated care models aiming to 
achieve these goals, including Canadian examples. 21–29 The Alberta Cardiac 
Access initiative improved collaborative care through expansion of Heart Failure 
Clinics (HFC) and training primary care physicians (PCP), pharmacists and 













British Columbia Cardiac Services also developed an integrative system based 
on the “hub and spoke” model to create collaboration with regional teams.31 
Thus, with respect to HF care in Canada, the status quo is unsustainable and 
system redesign is required. The CCS HF guidelines identify the features of an 




SPOKE-HUB-AND-NODE (SHN) MODEL OF CARE 
A SHN model has been promoted as a possible solution encompassing 
evidence-based recommendations for integrated care.2,3  This represents a 
systems approach to care guided by patient risk and complexity, including 
beneficial HF management components, with healthcare professionals working 
collaboratively for optimal management.33,34 
 
Heart Failure Clinic  
Studies demonstrate HFCs improve outcomes including mortality, hospital 
readmissions, prescribing patterns, QOL and system costs.18,19,23,26,33,34  The 
Canadian, American and European HF Guidelines all recommend 
multidisciplinary HFCs.32,38,39  Recently a review confirmed a lower incidence of 
HF hospitalizations and all-cause mortality associated with specialized HFCs.35  
However, only patients with a minimum of 3 months follow-up benefit (OR 0.52; 
P=0.0009), while those followed less than 3 months do not (OR 0.91; P=0.70). 
Patients with recent hospitalization benefited (OR 0.51; P=0.0001), those without 
did not (OR 0.95; P=0.70).  This suggests more prolonged follow-up is required, 
as well as the need to target higher risk, recently hospitalized patients for HFCs. 
Sochalski et al., reanalyzed data from 10 trials of HF case management 
programs assessing if delivery methods influence program effectiveness.28 They 
found a multidisciplinary team more effective than a program with a single HF 
expert. Meeting with the patient in-person was more effective than telephone 
communication. A combination of a multidisciplinary team and in-person 
communication was most effective to reduce readmissions.  Although HFCs are 
effective the number of clinics in any geographical area is limited.2,35 Currently, 
most HF patients are cared for by PCPs and generalists. In part, the limited 
number of clinics is due to lack of designated government funding.  However, 
variable clinic structures pose difficulties for developing an appropriate funding 
model.2,35 A consistent funding structure is required.   
 
 
HF Nurse Specialist 
 Nurses play a valuable role in the CCM. A meta-analysis of HFC RCTs 
suggested clinics have a key role for specialist nurses.26 Two studies 
demonstrated nurse practitioner (NP) led clinics decrease HF and all-cause 
admissions, are cost effective, improve patient satisfaction, and lower one-year 
mortality.36,37  NPs managing HF independently as primary care providers is one 













younger (mean age 79.82 ± 7.39 80.25 vs. 81.56 ± 7.34) patients with fewer 
comorbidities, they demonstrated similar safety data for emergency room visits 
and increased likelihood of achieving guideline-recommended medications 
compared to PCPs.38  Specialized HF nurse involvement reduces hospital 
readmission rates versus generic nurses (30% vs 13%).44 A meta-analysis 
further emphasizes nursing involvement for HF management.39 Nurse home 
visits (RR 0.78; 95% CI 0.62-0.98) and disease management clinics (RR 0.80; 
95% CI 0.67-0.97) resulted in reductions of all-cause mortality. All-cause 
readmissions were reduced by nurse home visits (incident rate ratio 0.65; 95% CI 
0.49-0.86), nurse case management (incident rate ratio 0.77; 95% CI 0.63-0.95) 
and disease management clinics (incident rate ratio 0.80; 95% CI 0.66-0.97).   
 
Pharmacist Support 
Meta-analyses demonstrated pharmacists have a beneficial role for 
inpatient and outpatient HF management.40–43 Roles include patient education, 
resource within the HF team and collaborative medication management.41 A 
review showed pharmacist intervention decreased all-cause hospitalization (OR 
0.74; 95% CI 0.58-0.94). 42 There was a higher prescription rate of ACE inhibitor 
(OR 1.43; 95% CI 1.07 to 1.91) and beta-blocker (OR 1.92; 95% CI 1.24 to 2.96) 
in the intervention group.40 Another review demonstrated reduction of HF 
hospitalizations (OR, 0.69; 95% CI, 0.51-0.94); pharmacist collaborative care 
reduced HF hospitalizations (OR, 0.42; 95%CI, 0.24-0.74) more than pharmacist-
directed care (OR, 0.89; 95% CI, 0.68-1.17).44 With the recent USA FDA 
approval of a drug with a digital ingestion tracking system, the pharmacist role 
could expand in the future.  
 
Palliative Care Support 
 Despite the variable illness trajectory and uncertain prognosis of HF 
patients, much is to be gained from early inclusion of palliative specialists. 
Provision of palliative services should be based on assessment of need and 
symptom management rather than focusing on an individual’s life expectancy.18 
Accumulating evidence demonstrates palliative care should be delivered in an 
integrated manner.18,45–48 According to a recent review palliative care should add 
value through expert symptom management, facilitation of advance care 
planning, optimizing transitions and end-of-life care.47 Studies demonstrate 
improvement in QOL, symptom management and reduction in use of medical 
services.53,54,56,57 A review demonstrated reduction in hospital visits, overall 
admissions and length of stay.48 A meta-analysis of home-based palliative care 
found it lowered the risk of rehospitalization (RR 0.58; 95% CI 0.44, 0.77).48 The 
Palliative Care in Heart Failure (PAL-HF) study examined a longitudinal palliative 
care interdisciplinary intervention in advanced HF patients.46 Programs were 
delivered by specialty nurses and improvements in QOL were observed over a 
six-month period.  No differences were observed between the intervention group 
and usual care group for hospitalizations or mortality.46 
 













 There is inconsistent evidence regarding the benefit of telemonitoring and 
telehealth in the HF population. Some of the difficulty in comparison comes from 
heterogeneous models without detailed descriptions, varying levels of clinical 
support and differences in response to monitored parameters. Meta-analyses 
tend to show reductions in hospitalizations, mortality and economic benefit but 
have been criticized for including single-center, non-randomized and 
predominantly positive studies.49,50 Three of the largest multi-center RCTs did not 
show clinical benefit.51–53 Telehealth trials seem to show greater benefit when the 
usual care arm is suboptimal. Consistently in those trials showing benefit, 
patients in the telemonitoring arm were on higher doses of disease-modifying 
agents.50  Many reviews acknowledge the confusion surrounding the role of 
telehealth in HF, however multiple ongoing studies will better define the role of 
this technology.49,54   
 
Role of Solo Practitioners 
 PCPs and specialists play important roles in HF management. Patients 
with a cardiologist involved in their care experience improved outcomes in acute 
and outpatient settings.26,55,56 Boom et al., demonstrated patients hospitalized 
with HF cared for solely by a generalist were at increased risk of 30-day mortality 
(OR 1.50,;95 % CI 1.18–1.91).57 In the outpatient setting, it has been 
demonstrated combined PCP and specialist care results in lower one year 
mortality compared to PCP care alone.20,41 Collaborative care increases use of 
drug therapies and cardiovascular tests.58 Continuity of care is an important issue 
to recognize when considering care delivery, as we know providing follow-up 
soon after hospital  discharge, with a familiar physician, portends better patient 
outcomes.59 Furthermore, sole cardiology care confers a trend to increased 
mortality compared to collaborative care (HR 1.41; 95% CI 0.98-2.03; P=0.067), 
emphasizing the role of collaborative care.41 Given these data, collaborative care 
in HF is the current standard for achieving best patient outcomes.  
 
Levels of Care Delivery 
At present, management strategies essentially work in isolation.  The SHN 
model organizes care along a continuum where patients are triaged, among 
three levels of care, based on complexity and risk at any given time.  
Low risk or complexity patients can be cared for in a spoke, close to 
home, generally by PCPs. These patients will have well-controlled risk factors or 
fully diagnosed causes of HF and require medication optimization. It must be 
recognized that HF patients are never completely stable, so ongoing monitoring 
and care are essential in the spoke to detect early findings of decompensation.  
There should be patient and caregiver education with regular follow-up as 
required.  
Intermediate risk or complexity patients require more complex care 
provided by a hub. A specialist (an internist, cardiologist or in some cases a PCP 
with HF training) in a multidisciplinary team within a community clinic or hospital 
would provide care. This level of care may often be delivered close to the 













reversible causes of HF. Appropriate management at this level includes review of 
available evidence-based therapies, medication optimization and ongoing patient 
and caregiver education.  
High risk or complex patients require the most complex care delivered in a 
node. The node provides specialized multidisciplinary programs to stabilize and 
support patients.  HF physicians would have access to the full range of cardiac 
diagnostics and therapeutics, utilizing these to pursue sophisticated diagnostic 
modalities, implement complex medication regiments including device 
implementation.2 The strengths of this system would be established 
communication among the three levels with shared electronic medical records 
and providing optimal care as close as possible to the patient’s home.   
 
Patient Stratification 
The intensity of patient care will fluctuate over time based on changing 
complexity and risk. Inherent in the system is a pre-arranged set of criteria for 
referral and risk stratification. Initial assessment and continued reassessment of 
longer term prognosis and risk, should be assessed using standardized risk 
scores for mortality such as those suggested in the 2017 CCS HF guidelines.32 
Risk stratification, including frailty, should be the basis of reallocation between 
levels. Using assessments such as New York Heart Association (NYHA) 
functional classification, could serve to assess patient symptom severity and 
eligibility for care at each level. For example, patients with NYHA class I-II 
symptoms could be managed at a spoke, NYHA class II-III at a hub, and NYHA 
class III-IV at a node. NYHA classification is often used in this capacity and has 
been shown to be a valid measure of functional status and important in 
prognosticating HF.60 Despite this, there are questions regarding its 
reproducibility as there is no consistent method of assessment and there is 
difficulty distinguishing NYHA class II and III symptoms objectively.60–63 Concerns 
regarding NYHA class assessment in the elderly population stems from the 
inability to characterize co-morbid cardiac and non-cardiac conditions which may 
contribute to frailty and complexity of patients. Given the increasing prevalence of 
elderly HF patients this is an issue which warrants special consideration. The 
international Resident Assessment Instrument (interRAI) assessment system 
was developed by a large, multinational network of researchers to specifically 
address the care of complex and frail seniors. Within interRAI systems, the 
Changes in Health, End-stage disease, Signs and Symptoms (CHESS) scale 
was developed and has well-established reliability and validity.64 It takes into 
consideration six items including weight gain, dietary intake, dyspnea, change in 
cognition, unstable patterns of cognition, function or behavior. When combined 
with determination of need for assistance when ambulating, these items have 
been shown to be a more powerful prognostic indicator than NYHA class in 
elderly HF patients.62 InterRAI assessment systems are mandated in home and 
long-term care across most of Canada. Since HF patients with concomitant co-
morbidities are at increased risk of poor outcomes this is an important system to 
consider when stratifying patients.65 HF patients are more likely to be diagnosed 

















In chronic diseases, generally 70-80% of patients can be managed in low 
acuity settings.66 HFCs in a primary care setting, with appropriate training and 
support, can manage the majority of low acuity patients with a less intense 
program for ongoing monitoring, with an aim to accommodate the needs of the 
growing population.3,27,28,33  This would also allow for continuity of care, at a 
vulnerable period of transition.67 A patient may have NYHA class II symptoms 
and be started on medication in the community where their chronic needs are 
managed in the spoke with availability for support and consultation from the hub 
for medication optimization and possibly the node for more sophisticated 
diagnostic testing. At some point in time, they may destabilize during an acute 
HF exacerbation requiring immediate care in the hub due to proximity and 
increased acuity; with transfer to the node, as required, for more advanced 
cardiac management. The same process could happen in reverse upon 
discharge, where the patient may initially require frequent visits for management 
in the hub, but when stabilized may access the spoke. This is important because 
the patient’s home environment provides a sense of community that facilitates re-
enablement after hospital discharge.68 Utilization of this model would shift care to 
the community, minimizing acute care bed usage and cost to the system while 
maintaining optimal care.69–71  
 
Implementation 
This proposed system allows shared patient care among healthcare 
providers within the SHN network, ensuring timely access depending on the 
patient’s needs and preferences. This may involve direct patient care or 
accessible consultation and/or capacity building provided by the team at the 
node. Actualization of this model would necessitate the development of trained 
professionals, likely in primary care settings, to support spoke and hub care. This 
would adapt current care settings, where PCPs and generalists follow most 
patients, to work within the model for ongoing continuity of care. Adaptations 
from other functioning clinic models of multidisciplinary care, such as the memory 
clinic model, offer suggestions regarding capacity building in primary care.72 The 
memory clinic team typically consists of a PCP, 2-3 nurses and a social worker. 
A geriatric specialist is linked to each clinic and provides consultation support. 
Team members use standard assessments to determine patient and caregiver 
needs and work collaboratively to optimize medication and disease specific 
issues.73 This initiative, shows high levels of patient and caregiver satisfaction, 
high-quality care and decreased need for direct specialist consultation.72–76 
Education, ongoing support and opportunity for professionals to maintain 
competencies through professional development are required. Building this 
relationship will establish close working connections and opportunities to develop 













Implementation of a SHN model of care will take several system, program 
and provider level initiatives (and full discussion is beyond the scope of this 
paper). For example, system redesign requires capacity planning that identifies 
opportunities to make better use of current healthcare resources through 
realignment and reallocation, while recognizing that new services and system 
policies also will be required.  We know that delivery of care for HF in a HFC 
would optimize outcomes for high risk patients. We have also acknowledged the 
limitations to this model including distribution, healthcare provision and access to 
appropriate care personnel. Taking healthcare out of the current brick-and-mortar 
structures we are accustomed to, may help us to bridge some of these barriers. 
In a meta-analysis by McAlister et al. looking at HFCs, a secondary analysis 
showed no difference between clinic and home-based programs in reducing 
mortality and hospitalizations.21 This is consistent with a number of reviews that 
have echoed these results.78 Nurse home visits were also shown in a recent 
systematic review and network meta-analysis to decrease all-cause mortality and 
all-cause readmissions.39 Examining the Geriatric Assessment for Acute Care of 
Elders (ACE) model, we can start to extrapolate from RCT data, that a model of 
integrated and home-based care is plausibly accomplished providing excellent 
patient care and changing system utilization.79 Telemonitoring (discussed above) 
may also find its niche in assisting to develop integrated care delivery systems as 
it appears to have benefit when used in these environments. Funding models for 
health care provider remuneration have been identified as ongoing barriers to 
integrative care.72,80 Organizing care around a patient’s primary medical condition 
and providing bundled funding rather than fee-for-service models may encourage 
collaboration across care environments and within multidisciplinary teams.80 It is 
important to evaluate variability and share learnings among systems to improve 
care. The difficulty lies in obtaining data across the various jurisdictions in 
Canada.23,24,30,31,33,68,81–83 In fact only the 30-day hospital readmission HF quality 
indicator can be measured across Canada, emphasizing need for standardized 
evaluation of care. 84  System capacity planning for HF will require accurate data, 
complex analytics and modeling, jurisdictional scans, and extensive stakeholder 
consultation to ensure that appropriate structures, processes, and resources are 
















As the baby boomer generation ages, seniors will account for an 
increasingly larger percentage of the population in Canada. This reality is the 
primary driver for the growing HF population and the increased demands on the 
healthcare system.  
The substantial burden demands a systems approach for organizing HF 
care that includes key principles of the CCM, encourages a multidisciplinary team 
approach, and integrates care between primary and specialty care services. The 
SHN model aims to improve outpatient HF care through its foundation in proven 
concepts of integrated care while accounting for the unpredictable trajectory of 
the illness. This model, which has been used successfully in other chronic 
diseases such as renal disease in Ontario, has the potential to unify regional HF 
care across the country. This would eliminate the need for isolated initiatives of 
CCM and centralize services in the hopes of preserving quality, patient-centered 
care at an affordable cost to the Canadian public. 
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Table 1: Necessary features of successful health system integration. 
Reproduced from the 2017 Comprehensive Update of the CCS Guidelines for the 
Management of HF, Table 43; with permission from Elsevier. 
 
Feature Description 
Program integration and care 
coordination  
 
Shared and standardized information system 
accessible from any point in the care network 
Shared care plan with clearly defined patient-
centred goals of care, and mutually understood 
and agreed- upon provider (formal and informal) 
responsibilities  
An organizational framework clearly specifying 
the linkages between constituents of the care 
network and community-based services  
Clearly defined protocols to facilitate seamless 
transitions and navigation for patients and 
providers between levels and sites of care, and 
are anchored in primary care  
Human resource elements  
 
In addition to clinical staff, additional resources 
should include  
• Program to support coordination, 













• Access to continuing medical education to 
support knowledge translation  
Access to care  
 
Standardized risk stratification criteria to ensure 
timely referral and access to appropriate care;  
Access to other services:  
• Specialists: cardiology, geriatrics, 
psychiatry, internal medicine, 
rehabilitation;  
• Palliative care, spiritual care; and  
• Home care and community support 
services 
Quality improvement and 
outcome measurement  
 
 Measurement and submission of mandated 
quality measures to appropriate authority;  
 Measurement of Quality Indicators, as defined 
according to the Canadian Cardiovascular 
Society Quality Indicators Working Group 


















Figure 1: Conceptual design of the spoke-hub-and-node model of integrated 
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